Coutinho, Walmir http://orcid.org/0000-0003-3945-0204
Halpern, Bruno http://orcid.org/0000-0003-0973-5065
Article History
Received: 16 August 2023
Accepted: 25 November 2023
First Online: 3 January 2024
Declarations
:
: Not applicable.
: Not applicable.
: Walmir Coutinho is a speaker for Novo Nordisk, Brace Pharma and Takeda and an advisory board member of Merck, Novo Nordisk, Abbott Diabetes Care, Takeda and EMS. Bruno Halpern is an advisory board member of Merck, Novo Nordisk, Lilly, and Astra Zeneca and has received funding for lectures from Novo Nordisk, Lilly, Astra Zeneca Boehringer Ingelheim, Takeda, and Abbott Nutrition.